Groundbreaking Antibiotic Selectively Targets Resistant Gram-Negative Bacteria While Preserving Beneficial Gut Microbiome

A new antibiotic, lolamicin, uses a unique mechanism to selectively target and kill antibiotic-resistant Gram-negative bacteria while leaving beneficial gut microbes unharmed, offering a promising approach to combat deadly infections.